Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Public health advocate wants Avandia study halted
Yahoo/AP
Wednesday, April 28, 2010 - 5:49pm
tags:
GSK, Avandia, diabetes, Public Citizen, Sidney Wolfe
Earnings Preview: Merck
Yahoo/Zacks.com
Wednesday, April 28, 2010 - 5:45pm
tags:
Merck, earnings
Pfizer developing "bio-betters," seeking rare blood disorder drugs
Fierce Biotech
Wednesday, April 28, 2010 - 11:36am
tags:
Pfizer
BioCryst rallies on gout study; AMAG shares fall
Marketwatch
Wednesday, April 28, 2010 - 11:33am
tags:
Amag Pharmaceuticals, Biocryst, gout
Healthcare overhaul's price tag grows to $105B
Fierce Pharma
Wednesday, April 28, 2010 - 10:58am
tags:
healthcare reform
BioCryst 1Q loss narrows on peramivir revenue
Yahoo/AP
Wednesday, April 28, 2010 - 10:57am
tags:
Biocryst, earnings, peramivir
Jazz Enters Oversold Territory
Yahoo/Zacks.com
Wednesday, April 28, 2010 - 10:56am
tags:
Jazz Pharmaceuticals
A Genentech Eye Treatment Is Found to Help Prevent Vision Loss in Diabetics
NY Times, NY
Wednesday, April 28, 2010 - 10:55am
tags:
Lucentis, diabetes, Genentech
Research Community Hails Stem Cell Approval
Yahoo/Indie Research
Wednesday, April 28, 2010 - 10:19am
tags:
stem cells
MermaiHD Madness: NeuroSearch's Statistically Significant Snafu
InVivo
Wednesday, April 28, 2010 - 9:17am
tags:
MermaiHD, Neurosearch, Huntington's disease
Actos diabetes drug to go generic in 2 years
Chicago Tribune, IL
Wednesday, April 28, 2010 - 9:10am
tags:
Actos, generics, Takeda, diabetes
Whistleblower Twice Over: First Lilly, Now AstraZeneca
WSJ Online
Wednesday, April 28, 2010 - 9:01am
tags:
whistleblowers, Eli Lilly, AstraZeneca, off-label, Seroquel
Biotech Venture Capital Could Finally Be Heating Up Again -- Maybe
BNET Pharma
Wednesday, April 28, 2010 - 8:58am
tags:
biotech, venture capital
Mylan starts shipping generic version of Flomax
Yahoo/AP
Wednesday, April 28, 2010 - 8:57am
tags:
Mylan, generics, Flomax, Impax, enlarged prostate
AstraZeneca, Seroquel And Product Liability
Pharmalot
Wednesday, April 28, 2010 - 8:45am
tags:
AstraZeneca, Seroquel, product liability
CSL Vaccine Probe Widens in Australia After Seizures
Bloomberg
Wednesday, April 28, 2010 - 8:10am
tags:
CSL, vaccines, Australia, H1N1
Biotech's Big Day: The Industry Is Finally Profitable, Mostly Thanks to Cost-Cutting -- Not Higher Sales
BNET Pharma
Wednesday, April 28, 2010 - 7:41am
tags:
earnings, biotech, Roche, Genentech
GlaxoSmithKline profit up, signs of U.S. recovery
Marketwatch
Wednesday, April 28, 2010 - 7:40am
tags:
GSK, earnings
Genzyme May Sell Off Noncore Businesses; Will Disclose Unit Detail
WSJ Online
Tuesday, April 27, 2010 - 9:37pm
tags:
Genzyme
Consultant: Smart biotech money betting on innovation
Fierce Biotech
Tuesday, April 27, 2010 - 9:36pm
tags:
biotech, venture capital

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.